Phillips-Medisize

Phillips-Medisize is a contract development and manufacturing organization focused on drug delivery, diagnostic, and medtech devices for biopharma, life sciences, and healthcare customers.

• End-to-end design, engineering, and contract manufacturing of drug delivery devices and combination products for biopharma.
• Development and production of in vitro diagnostic and point-of-care devices for clinical and laboratory use.
• User-centered design, human factors engineering, and usability services for regulated medical and pharmaceutical products.
• Electronics, connectivity, and digital health integration for connected drug delivery and medtech systems.
• Global, regulated supply chain, quality, and lifecycle management services for medical and pharmaceutical device programs.

More About Phillips-Medisize

Phillips-Medisize operates as a contract development and manufacturing partner for biopharmaceutical, medical technology, and diagnostic companies that need to design, industrialize, and produce regulated devices at scale. Its offerings align with enterprise Research and Development (R&D), device development, and operations teams that require external capacity for complex drug delivery systems, combination products, and diagnostic instruments under medical device and pharmaceutical regulatory frameworks.

The company supports programs across the full product lifecycle, from concept design, industrial design, and human factors engineering through detailed mechanical and electronics engineering, Design for Manufacturability (DFM), tooling, and large-scale production. Its work spans autoinjectors, pen injectors, on-body delivery systems, inhalation devices, prefilled syringes with device components, and other combination products (drug delivery category), as well as in vitro diagnostic and point-of-care devices (diagnostics category) and various medtech platforms (medical devices category).

In enterprise and institutional environments, Phillips-Medisize typically integrates into customer governance processes that address risk management, quality management systems, and regulatory submissions. The company operates under ISO and medical device quality standards (quality and compliance category), and its services are structured to support compliance with regulations such as those governing combination products, medical devices, and in vitro diagnostics. This alignment enables pharmaceutical and device manufacturers to outsource portions of design, engineering, and manufacturing while maintaining regulatory control and oversight.

The organization employs multidisciplinary engineering capabilities, including mechanical engineering, electronics and embedded systems, software integration, and fluidics and microfluidics where applicable (product development category). It also applies human-centered design methods and usability engineering (human factors category) to support safety and effectiveness claims, which are required for regulatory submissions and post-market surveillance in many jurisdictions.

From a production and supply chain perspective, Phillips-Medisize provides injection molding, assembly, automation, and packaging services for high-volume device manufacturing (manufacturing services category). The company operates global facilities that enable regionalized production and supply for large pharmaceutical and medtech enterprises, with structured quality controls, validation, and traceability processes to meet enterprise-level requirements.

Within an enterprise technology and procurement directory, Phillips-Medisize fits into categories such as contract design and development services for drug delivery and medtech, contract manufacturing organization (CMO) and contract development and manufacturing organization (CDMO) services (outsourced manufacturing category), and design and engineering services for regulated healthcare products. Its offerings are used by R&D, device engineering, supply chain, and operations leaders who need an external partner to bring complex, regulated devices from early concept through validated manufacturing and commercial supply.